Monkeypox (Mpox): Clinical Trials

3 trials for Monkeypox (Mpox), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 not yet recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 2, Not yet recruiting 1

Follow Monkeypox (Mpox): new trials by email Literature Review of Monkeypox (Mpox) trials Research Report on Monkeypox (Mpox)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo
MVA-SIBP low dose, MVA-SIBP high dose, MVA-BN - Monkeypox (Mpox)
Phase 2Not yet recruitingShanghai Institute Of Biological Products1802025-12-312025-11-28
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Jynneos, MVA-BN (Quail) - Monkeypox (Mpox)
Phase 2Active not recruitingBavarian Nordic9702025-10-272026-04-08
Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections
MVA-BN - Monkeypox (Mpox)
Phase 2Active not recruitingBavarian Nordic4602024-10-212025-11-24

Narrower conditions

Mpox, Monkeypox (3)

Broader conditions

Animal Diseases (3)  ·  DNA Virus Infections (3)  ·  Infections (3)  ·  Poxviridae Infections (3)  ·  Primate Diseases (3)  ·  Rodent Diseases (3)  ·  Virus Diseases (3)

Interventions

smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic (3)

Sponsors

Bavarian Nordic (2)  ·  Shanghai Institute Of Biological Products (1)

Countries

Democratic Republic of the Congo (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Hypolite Muhindo Mavoko (1)

Results publications

PMID 42372625